Endoscopic Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Application, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Endoscopic Ultrasound Market size was valued at USD 1.72 billion in 2026 and is projected to grow at a 6.51% CAGR from 2027 to 2036, attaining USD 3.23 billion by 2036. The industry revenue for 2027 is estimated at USD 1.81 billion.
Get more details on this report
Request Free Sample ReportEndoscopic Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America held 32.86% share in 2026 supported by established gastrointestinal diagnostic pathways, advanced hospital and endoscopy infrastructure, routine use in lesion staging, and availability of trained specialists.
- Asia Pacific is projected 7.8% CAGR driven by rising hospital investment, improving access to gastrointestinal specialists, expanding endoscopy platforms, and increasing use in referral centers.
Segment Momentum
- Lung cancer held a 44.71% share in 2026 due to the established role of endoscopic ultrasound in lesion evaluation, tissue sampling, and lymph node assessment for diagnosis and staging.
- Needles are the fastest-growing product segment as demand rises for minimally invasive tissue acquisition and targeted biopsy procedures that support pathology and treatment decision-making.
Market Expansion Drivers
- Rising pancreatic, lung, and colorectal cancer burden driving endoscopic ultrasound demand.
- Advancements in interventional endoscopic ultrasound devices enhancing diagnostic and therapeutic precision.
- Expanding R&D in ultrasound imaging and minimally invasive gastrointestinal procedures.
Leading Market Participants
- Major players in the endoscopic ultrasound market include Olympus Corporation (Japan), Boston Scientific Corporation (United States), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), HOYA Corporation (Japan), Cook Medical LLC (United States), CONMED Corporation (United States), SonoScape Medical Corp. (China), STERIS plc (Ireland), Medi-Globe GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.72 billion
- 2027 Estimated Market Size: USD 1.81 billion.
- Projected Market Size: USD 3.23 billion by 2036
- Growth Forecast: 6.51% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Lung Cancer (Application) | Endoscope (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Gastrointestinal Cancer (Application) | Needle (Product) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising pancreatic, lung, and colorectal cancer burden driving endoscopic ultrasound demand
The increasing incidence of pancreatic, lung, and colorectal cancers will drive the endoscopic ultrasound market as clinicians require detailed imaging to identify lesions, assess disease extent, and support treatment planning. Endoscopic ultrasound combines endoscopic visualization with high-resolution ultrasound imaging, allowing physicians to examine structures surrounding the gastrointestinal tract and obtain tissue samples from suspicious areas. Its ability to support staging and biopsy procedures is particularly valuable in complex cancer cases where conventional imaging may not provide sufficient anatomical detail.
Advancements in interventional endoscopic ultrasound devices enhancing diagnostic and therapeutic precision
Advancements in interventional devices are strengthening the endoscopic ultrasound market by expanding the range of procedures that can be performed with greater targeting accuracy. Improved biopsy needles, imaging capabilities, and therapeutic accessories enable clinicians to obtain tissue samples and access lesions or fluid collections with enhanced procedural control. The development of increasingly sophisticated equipment is also supporting applications that combine imaging with minimally invasive intervention, helping reduce reliance on more invasive approaches for selected gastrointestinal and adjacent-organ procedures.
Expanding R&D in ultrasound imaging and minimally invasive gastrointestinal procedures
Expanding research into ultrasound imaging technologies and minimally invasive gastrointestinal techniques will propel the endoscopic ultrasound market by improving image quality, procedural guidance, and clinical utility. R&D efforts are focused on enhancing visualization of small or difficult-to-access lesions while developing techniques that allow diagnostic assessment and intervention within the same procedure. Continued innovation in imaging systems, endoscopic platforms, and procedure-specific tools is broadening the role of endoscopic ultrasound across complex diagnostic and therapeutic workflows.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pancreatic, lung, and colorectal cancer burden driving endoscopic ultrasound demand | 2.00% | High | North America, Europe | High | Near Term |
| Advancements in interventional endoscopic ultrasound devices enhancing diagnostic and therapeutic precision | 1.60% | High | North America, Asia Pacific | High | Mid Term |
| Expanding R&D in ultrasound imaging and minimally invasive gastrointestinal procedures | 1.40% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the endoscopic ultrasound market, North America held the largest share of 32.86% in 2026, supported by advanced gastrointestinal care infrastructure, broad adoption of minimally invasive diagnostic procedures, and strong clinical acceptance of image-guided endoscopic techniques. The region benefits from established healthcare systems, experienced specialist networks, and favorable access to sophisticated imaging and endoscopy equipment. Growing emphasis on earlier disease detection, precision diagnosis, and less invasive approaches is sustaining demand, while continued investment in hospital technology and procedural capabilities reinforces North America's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, rising awareness of advanced diagnostic procedures, and increasing access to specialized gastrointestinal care. Improvements in hospital facilities and the gradual adoption of technologically advanced endoscopic equipment are widening the addressable patient base across developing healthcare systems. Growing healthcare expenditure, increasing demand for early diagnosis, and efforts to strengthen specialist services are expected to support sustained market expansion as healthcare providers increasingly incorporate advanced minimally invasive diagnostic modalities.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical IntegrationGermany prioritizes endoscopic ultrasound within specialized gastroenterology centers where diagnostic accuracy and multidisciplinary treatment planning are essential. Hospitals focus on integrating advanced imaging technologies that support complex interventions and standardized clinical workflows.
France 🇫🇷
Specialized Diagnostic ExpansionFrance strengthens the endoscopic ultrasound market by expanding specialized diagnostic services for gastrointestinal diseases and oncology. French healthcare facilities prioritize coordinated clinical pathways that combine imaging expertise with minimally invasive treatment planning.
Italy 🇮🇹
Hospital-Based Procedure EnhancementItaly focuses on improving access to endoscopic ultrasound within tertiary hospitals managing complex gastrointestinal conditions. Italian healthcare providers continue modernizing endoscopy units and reinforcing specialist expertise to enhance diagnostic and interventional capabilities.
Japan 🇯🇵
Innovation-Driven ImagingJapan advances the endoscopic ultrasound market through continual refinement of imaging systems and early disease detection practices. Japanese healthcare institutions emphasize high-quality visualization and procedure optimization to strengthen diagnostic confidence across digestive disorders.
South Korea 🇰🇷
Technology-Focused EndoscopySouth Korea supports adoption of endoscopic ultrasound through technologically advanced hospitals and expanding therapeutic endoscopy capabilities. Clinical providers in South Korea increasingly integrate imaging innovations that improve procedural efficiency and support minimally invasive care.
United States 🇺🇸
Advanced Procedure AdoptionThe U.S. emphasizes wider integration of endoscopic ultrasound across gastrointestinal oncology, pancreatic disease, and minimally invasive diagnostics. Healthcare providers continue investing in advanced imaging platforms and physician training to improve procedural precision and expand clinical applications.
Segment Leadership and Growth Trends
Endoscopic Ultrasound Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Lung Cancer (Largest Segment) vs Gastrointestinal Cancer (Fastest-Growing Segment)
Lung cancer accounted for the largest share of the endoscopic ultrasound market at 44.71% in 2026, supported by the growing clinical importance of minimally invasive imaging and tissue assessment in the diagnosis and staging of thoracic malignancies. Endoscopic ultrasound can provide detailed visualization of structures surrounding the airways and support targeted sampling of suspicious lesions or lymph nodes, helping clinicians obtain information needed for treatment planning. Its ability to combine imaging with guided tissue acquisition contributes to more informed diagnostic pathways and can reduce reliance on more invasive approaches in appropriate cases. Increasing emphasis on accurate cancer staging and personalized treatment selection continues to reinforce the relevance of endoscopic ultrasound in lung cancer evaluation.
Gastrointestinal cancer is advancing as the fastest-growing application segment as clinicians increasingly use endoscopic ultrasound to characterize lesions, evaluate disease extent, and guide tissue sampling across the gastrointestinal tract. The technology offers high-resolution visualization of tissue layers and structures adjacent to the digestive tract, making it valuable for assessing abnormalities that may not be fully characterized through conventional imaging alone. Greater focus on early and precise cancer diagnosis is encouraging the integration of imaging and biopsy capabilities within a single procedure. As gastrointestinal oncology increasingly relies on detailed disease characterization to inform treatment decisions, demand for endoscopic ultrasound applications in gastrointestinal cancers is gaining momentum.
Product Segment Analysis: Endoscope (Largest Segment) vs Needle (Fastest-Growing Segment)
Endoscopes held the largest share of the endoscopic ultrasound market at 35.87% in 2026, reflecting their fundamental role in delivering real-time ultrasound visualization during endoscopic procedures. These systems enable clinicians to examine gastrointestinal and surrounding structures with detailed imaging while supporting diagnostic and interventional procedures. Their broad clinical utility across oncology, gastroenterology, and other specialized applications strengthens demand for advanced endoscopic ultrasound equipment. Improvements in imaging quality, procedural functionality, and integration with complementary diagnostic capabilities are further increasing the value of endoscopes within modern clinical workflows, reinforcing their leading position in the product landscape.
Needles are experiencing the fastest growth as demand rises for precise, ultrasound-guided tissue sampling and minimally invasive interventional procedures. Endoscopic ultrasound-guided needles enable clinicians to obtain tissue or fluid samples from lesions and structures that may otherwise be difficult to access safely, supporting more accurate diagnostic assessment. Their importance is increasing alongside the broader shift toward image-guided procedures that combine visualization and intervention within a single clinical workflow. Advances in needle design, sampling performance, and compatibility with increasingly sophisticated endoscopic ultrasound procedures are expanding their clinical utility and supporting rapid adoption across diagnostic and oncology applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Gastrointestinal Cancer, Lung Cancer, Pancreaticobiliary Disease, Others | Lung Cancer | Gastrointestinal Cancer |
| Product | Endoscope, Ultrasound Probe, Needle, Accessories, Ultrasonic Processors | Endoscope | Needle |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Prominent players in the endoscopic ultrasound market:
1. Olympus Corporation (Japan)
2. Boston Scientific Corporation (United States)
3. Medtronic plc (Ireland)
4. FUJIFILM Holdings Corporation (Japan)
5. HOYA Corporation (Japan)
6. Cook Medical LLC (United States)
7. CONMED Corporation (United States)
8. SonoScape Medical Corp. (China)
9. STERIS plc (Ireland)
10. Medi-Globe GmbH (Germany)
Growth in the endoscopic ultrasound market is being fueled by the introduction of advanced imaging platforms and precision-guided diagnostic systems that improve procedural accuracy and clinical efficiency. Increased focus on minimally invasive healthcare solutions and ongoing investment in enhanced visualization technologies are further supporting innovation across the sector.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Olympus Corporation (Japan) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| FUJIFILM Holdings Corporation (Japan) | |||||||
| HOYA Corporation (Japan) | |||||||
| Cook Medical LLC (United States) | |||||||
| CONMED Corporation (United States) | |||||||
| SonoScape Medical Corp. (China) | |||||||
| STERIS plc (Ireland) | |||||||
| Medi-Globe GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Cook Medical | May-24 | Cook Medical commercialized the EchoTip AcuCore EUS Biopsy Needle, optimized to secure clean gastrointestinal core biopsy samples under endoscopic ultrasound guidance. |
| Fujifilm India | Feb-24 | Fujifilm India executed the first commercial deployment of its ALOKA ARIETTA 850 Diagnostic Ultrasound System at Fortis Hospital in Bengaluru for advanced gastrointestinal mapping. |
| EndoSound | Jan-24 | EndoSound secured US FDA 510(k) regulatory clearance for its endoscopic ultrasound system designed to improve diagnostic accuracy during routine gastrointestinal endoscope evaluations. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoscopic Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procedure Type | Diagnostic EUS, EUS-Guided Tissue Sampling, EUS-Guided Therapeutic Procedures |
| Technology Platform | Radial EUS, Linear EUS, Hybrid EUS Systems |
| Procedure Purpose | Diagnostic Imaging, Tissue Acquisition, Therapeutic Intervention |
Endoscopic Ultrasound Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Hospital Procurement and Capital Investment Outlook |
|
| AI and Image-Guided Innovation Adoption Outlook |
|
| Ambulatory Surgery Center Expansion Impact Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the endoscopic ultrasound market?
How is the endoscopic ultrasound industry size expected to evolve during the forecast period?
How are advances in endoscopic ultrasound technology expanding clinical adoption?
Why are hospitals expanding endoscopic ultrasound capabilities for oncology care?
Why is lung cancer the largest application segment in the endoscopic ultrasound market?
Which product segment is growing fastest in the endoscopic ultrasound market?
Why does North America hold the leading position in endoscopic ultrasound?
What is driving Asia Pacific growth in endoscopic ultrasound adoption?
Who are the leading players in the endoscopic ultrasound landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization